FDA.reportPublic FDA data

National Council for Prescription Drug Programs indexing - billing unit

Manufacturer
National Council for Prescription Drug Programs
Effective date
2012-07-24
Label type
Indexing - Billing Unit
Version
1
Source
full-release
Hydrated at
2026-06-05 01:08:11

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
13533-700-01EA - Each13533-7000ca3e2cc-b57d-4ebd-bafa-954b3288ec7d12012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
13533-70013533-700-01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103174prolastin,prolastin-c,prolastin-c liquidAlpha-1-Proteinase Inhibitor (Human)351(a)Rx2026-09-01

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.